The loss of CMV-specific CD27(-) T-cell effectors in a patient with recurrences of CMV retinitis is independent of HIV-1 viremia.
D'Offizi
G
G
Ciapparoni
V
V
Gioia
C
C
Goletti
D
D
Agrati
C
C
Pucillo
L P
LP
Narciso
P
P
Poccia
F
F
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology*; D000328:Adult; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D017726:Cytomegalovirus Retinitis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology*; D015497:HIV-1 / Q000187:drug effects / Q000276:immunology*; D006801:Humans; D008297:Male; D011379:Prognosis; D012008:Recurrence; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D013601:T-Lymphocytes / Q000276:immunology / Q000502:physiology; D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7 / Q000032:analysis*; D014766:Viremia / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*
D018127:Tumor Necrosis Factor Receptor Superfamily, Member 7